[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-370617-105":59,"doc-detail-370617-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","development-of-an-innovative-approach-for-early-diagnosis-of-cervical-cancer-using-tcr-like-antibodies-targeting-hpv18-e6-and-e7-peptides","Development of an innovative approach for early diagnosis of cervical cancer using TCR‑like antibodies targeting HPV18 E6 and E7 peptides","","Cervical cancer is the fourth most prevalent cancer among female patients globally, driven largely by persistent high-risk human papillomavirus (HPV) infections. The viral oncoproteins E6 and E7 promote cellular transformation and maintain the malignant phenotype. T cell receptor (TCR)-like antibodies may enable diagnosis by capturing HPV oncogenic peptides presented in MHC. Here, a human domain antibody phage library was screened using HPV18 (E6 and E7) peptide–MHC (p-MHC-A24) complexes to identify target-specific TCR-like antibodies.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/development-of-an-innovative-approach-for-early-diagnosis-of-cervical-cancer-using-tcr-like-antibodies-targeting-hpv18-e6-and-e7-peptides/370617/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/development-of-an-innovative-approach-for-early-diagnosis-of-cervical-cancer-using-tcr-like-antibodies-targeting-hpv18-e6-and-e7-peptides/370617.png","ImageObject",300,407,{"name":92,"@type":93},"Fahsai","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",15,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the diagnostic goal of the study regarding cervical cancer?","Question",{"text":113,"@type":114},"To develop an early diagnostic approach using TCR-like antibodies that specifically recognize HPV18 E6 and E7 peptide–MHC complexes.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were TCR-like antibodies identified in this work?",{"text":118,"@type":114},"A human domain antibody (DAB) phage library was screened against synthesized HPV18 (E6 and E7) peptide–major histocompatibility complex (p-MHC-A24) targets.",{"name":120,"@type":111,"acceptedAnswer":121},"What do the results indicate about the antibodies?",{"text":122,"@type":114},"Three TCR-like DABs were identified that specifically target HPV18 (E6 and E7) p-MHC-A24 complexes, with characterization of their CDR regions and affinity evaluation by western blotting and ELISA.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},370617,1790218683,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":31,"preview_page_count":19,"preview_urls":145},549768702563,"https://ap-avatar.wpscdn.com/avatar/8000c4aa63b76e948b?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786536092046926083","MOLECULAR MEDICINE REPORTS 32: 218, 2025  \nDevelopment of an innovative approach for early diagnosis of cervical cancer using TCR‑like antibodies targeting HPV18 E6 and E7 peptides  \nBASSAMALI SACHIT 1‑3 , SYLVIA ANNABEL DASS 1 , REHASRI SELVA RAJAN 1 , GEE JUN TYE 1,4 and VENUGOPAL BALAKRISHNAN 1  \n1Institute for Research in Molecular Medicine, University Sains Malaysia, Penang 11800, Malaysia; 2Laboratory of Molecular Biology, Thi Qar Health Directorate, Ministry of Health, Thi‑Qar 64001, Iraq; 3Department of Pathological Analysis, College of Applied Medical Science, Shatrah University, Thi‑Qar 64001, Iraq; 4Malaysian Institute of Pharmaceuticals and Nutraceuticals, National Institutes of Biotechnology Malaysia, Halaman Bukit Gambir, Gelugor, Penang 11700, Malaysia  \nReceived September 25, 2024; Accepted February 25, 2025  \nDOI: 10. 3892/mmr.2025.13583  \nAbstract. Cervical cancer is the fourth most prevalent cancer among female patients globally, largely due to persistent infections with high‑risk human papillomavirus (HPV) . Viral oncoproteins E6 and E7, produced by HPV, serve a role in driving cellular transformation and maintaining the malignant phenotype. T cell receptor (TCR)‑like antibodies serve as a potential diagnostic tool to capture the oncogenic peptide that is present in MHC. As these antibodies serve as innate antigen detectors, orchestrating immune responses against both cell surface and intracellular proteins . In the present study, a human domain antibody (DAB) phage library was screened by evaluating synthesized HPV18 (E6 and E7) peptide‑major histocompatibility complexes (p‑MHC‑A24) to identify target‑specific TCR‑like antibodies. The present study successfully identified three TCR‑like DABs that specifi‑ cally target HPV18 (E6 and E7) p‑MHC‑A24 complexes . Characterization of the amino acid sequences in the comple‑ mentarity‑determining regions 1, 2 and 3 was performed using VBASE2 and the international ImMunoGeneTics information  \nCorrespondence to: Dr Venugopal Balakrishnan, Institute for Research in Molecular Medicine, University Sains Malaysia, H53 Jalan Inovasi, Penang 11800, Malaysia  \nE‑mail: [venugopal@usm.my](venugopal@usm.my)  \nAbbreviations: CC, cervical cancer; HPV, human papillomavirus; TCR, T cell receptor; HLA‑A24, human leukocyte antigen within the HLA‑A serotype group; p‑MHC, peptide‑major histocompatibility complex; ADCC, antibody‑dependent cellular cytotoxicity; NCBI, National Centre for Biotechnology Information;β2m, β‑2‑microglobulin; IMGT, ImMunoGeneTics information system®  \nKey words: HPV18, cervical cancer diagnostics, HLA‑A24, T cell receptor‑like antibody, antibody phage display, cervical cancer immunotherapy  \nsystem®/vquest databases . Evaluation of soluble TCR‑like antibodies confirmed strong and selective affinity for the targets through western blotting and ELISA. The present study aimed to clarify the specificity of TCR‑like antibodies against specific targets and demonstrated that TCR‑like antibodies may serve as early diagnostic and immunotherapeutic tools for HPV‑associated cervical cancer.  \nIntroduction  \nCervical cancer (CC) ranks as the second leading cause of cancer‑associated mortalities in developing nations and the 10th in more affluent countries, highlighting a global disparity in incidence rate (1,2) . Human papilloma virus (HPV) strains 16 and 18 are responsible for ~70% of CC cases worldwide (3,4) . The genomes of HPV16 and HPV18 contain six early and two late open reading frames and a substantial non‑coding regulatory region (5) . The early genes of HPV18 are key for viral replication and pathogenesis. In infected cells, the viral oncoproteins E6 and E7 drive malignant cell prolif‑ eration and other cancer‑associated processes by inhibiting apoptosis (6). E6 binds p53 and Bcl‑2, inhibiting apoptosis and enabling cells to bypass cell cycle protective checkpoints, thus promoting uncontrolled cell division (7). E7 targets retinoblas‑ toma protein for ubiquitin","cbCaie1zrvX43trK","https://ap.wps.com/l/cbCaie1zrvX43trK","pdf",6336611,"English","# Abstract\n# Introduction","[{\"question\":\"What is the diagnostic goal of the study regarding cervical cancer?\",\"answer\":\"To develop an early diagnostic approach using TCR-like antibodies that specifically recognize HPV18 E6 and E7 peptide–MHC complexes.\"},{\"question\":\"How were TCR-like antibodies identified in this work?\",\"answer\":\"A human domain antibody (DAB) phage library was screened against synthesized HPV18 (E6 and E7) peptide–major histocompatibility complex (p-MHC-A24) targets.\"},{\"question\":\"What do the results indicate about the antibodies?\",\"answer\":\"Three TCR-like DABs were identified that specifically target HPV18 (E6 and E7) p-MHC-A24 complexes, with characterization of their CDR regions and affinity evaluation by western blotting and ELISA.\"}]","Development of an innovative approach for early diagnosis of cervical cancer using TCR‑like antibodies targeting HPV18 E6 and E7 peptides | PDF",1790189496,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/419c1f3686ae3f7108d9c9397d611797.webp",983,1357,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a25a06aa9eb479f037a0122c6aaedf4d.webp",982,1356,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/55dc381f2c91873dd87282b71bc1069d.webp",981,1354,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a2e43319e2fa26e1c92effb0f9766855.webp",980,1353]